Leadoptik Inc.

LEADOPTIK Inc. is a deep-tech medical device startup founded in 2020 and based in San Jose, California. The company specializes in advanced pulmonary imaging and biopsy technology for early-stage lung cancer detection. LEADOPTIK develops miniature optical probes utilizing its proprietary Last Inch Assessment™ (LIA™) Technology, which delivers high-resolution, real-time 3D microstructure imaging in ultra-thin formats. This innovation enables access to narrow lung airways that conventional bronchoscopes cannot reach, addressing a critical clinical gap in interventional pulmonology. The LIA™ Technology employs dielectric metasurfaces and nanofabrication techniques to achieve unprecedented precision in nodule assessment and biopsy guidance, reducing diagnostic uncertainty and improving patient outcomes. The company is backed by $5.25 million in funding and supported by leading venture capital partners including SOSV, Sony Innovation Fund, and Meta Venture Partners. LEADOPTIK's clinical advisory board includes pulmonologists from major academic medical centers, and the company is preparing for FDA submission.